PC

Procyon CorpOOTC PCYN Stock Report

Last reporting period 30 Sep, 2023

Updated 11 Nov, 2024

Last price

Market cap $B

0.002

Micro

Exchange

OOTC - OTC

PCYN Stock Analysis

PC

Uncovered

Procyon Corp is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

54/100

Moderate score

Market cap $B

0.002

Dividend yield

Shares outstanding

8.087 B

Procyon Corp. is a holding company, which engages in the development and marketing of proprietary medical products. The company is headquartered in Clearwater, Florida. Amerx develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its product lines include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, EXTREMIT-EASE Compression Garment and Advantagen Surgical Collagen. AMERX markets a line of AMERIGEL skin and wound care products made with Oakin, that promote healing in wound and problematic skin conditions, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder and Collagen Matrix. Its wound care product includes AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Hyrdocolloid Dressing, and AMERX Wound Care Kits.

View Section: Eyestock Rating